These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5740303)

  • 21. [Pathology of spastic muscles. Study of 26 patients].
    Streichenberger N; Mertens P
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):185-9. PubMed ID: 12746692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Retabolil and nerobolil treatment of children with familial spastic paralysis].
    Zhovnir IK; Krotiuk LM
    Pediatr Akus Ginekol; 1975; (1):25. PubMed ID: 1228607
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of spasticity with dantrolene sodium].
    Winnem M
    Tidsskr Nor Laegeforen; 1980 Oct; 100(29):1727-8. PubMed ID: 7008246
    [No Abstract]   [Full Text] [Related]  

  • 24. [Familial spinal spastic paralysis--case study of the evolution of the disease through 5 generations].
    Popov I; Nikolić V; Mitrović D
    Med Pregl; 1983; 36(11-12):515-7. PubMed ID: 6679880
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vesico-vaginal reflux in patients with hypospadia femina and spastic paresis].
    Dørup I; Gregersen E
    Ugeskr Laeger; 1986 May; 148(21):1281. PubMed ID: 3727113
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of spasticity in neurological disease by dantrolen-sodium (author's transl)].
    Chantraine A; van Ouwenaller C
    Nervenarzt; 1980 Jan; 51(1):50-4. PubMed ID: 7393365
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitative assessment of the effect of cyproheptadine on spastic paretic gait: a preliminary study.
    Wainberg M; Barbeau H; Gauthier S
    J Neurol; 1986 Oct; 233(5):311-4. PubMed ID: 3772412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic motor capacity in spastic paresis and its relation to prime mover dysfunction, spastic reflexes and antagonist co-activation.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1980; 12(3):93-106. PubMed ID: 7209447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alcohol-novocaine blockade in children with spastic paralysis].
    Sidorova NK; Shterenherts AIe; Koval'ova VIa
    Pediatr Akus Ginekol; 1971; 4():27-8. PubMed ID: 5150409
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperreflexia and spastic paralysis among New Caledonian leprosy patients.
    Brody JA; Yase Y; Chemier G; Philippe Y
    Am J Trop Med Hyg; 1969 Jan; 18(1):132-7. PubMed ID: 5764193
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases.
    Hecht MJ; Stolze H; Auf dem Brinke M; Giess R; Treig T; Winterholler M; Wissel J;
    Mov Disord; 2008 Jan; 23(2):228-33. PubMed ID: 17999430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased capillarization and a shift to fast myosin heavy chain IIx in the biceps brachii muscle from young adults with spastic paresis.
    Pontén EM; Stål PS
    J Neurol Sci; 2007 Feb; 253(1-2):25-33. PubMed ID: 17196619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of spastic spinal paralysis].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():478. PubMed ID: 5406915
    [No Abstract]   [Full Text] [Related]  

  • 35. [On familial spastic spinal paralysis].
    Eichhorn CK
    Z Arztl Fortbild (Jena); 1965 Jul; 59(13):729-31. PubMed ID: 5887148
    [No Abstract]   [Full Text] [Related]  

  • 36. Sensory evoked potentials in adult-onset progressive spastic paraparesis.
    Seyal M; Pedley TA
    N Y State J Med; 1984 Feb; 84(2):68-71. PubMed ID: 6583560
    [No Abstract]   [Full Text] [Related]  

  • 37. [The possibility of pharmacologic therapy of extrapyramidal hyperkineses with tiapride].
    Grass H; Gottschaldt M
    Psychiatr Neurol Med Psychol (Leipz); 1983 Apr; 35(4):222-9. PubMed ID: 6223330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [F response in spastic spinal paralysis (author's transl)].
    Komori T; Narita S; Matsunaga M; Kurahashi K; Takebe K
    Rinsho Shinkeigaku; 1981 Jun; 21(6):517-21. PubMed ID: 7296982
    [No Abstract]   [Full Text] [Related]  

  • 40. Attenuation of facial muscle spasticity with intramuscular phenol neurolysis.
    Greenbaum MG; Young MA; Frank JM
    Arch Phys Med Rehabil; 1993 Feb; 74(2):217-9. PubMed ID: 8431109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.